This site demonstrates one possible use of this domain. For acquisition, partnership, or investment inquiries, please use our contact link.
Ketalux
Safety

Safety, Risks, and Contraindications

Ketamine therapy is a real medical intervention with real risks. Reading honestly about those risks is the first responsible step.

Medically reviewed by: Pending medical review(draft)Last updated: May 18, 2026Evidence: Safety review

Common short-term effects

  • Dissociation and altered perception during dosing
  • Transient increases in blood pressure and heart rate
  • Nausea, dizziness, or coordination changes
  • Emotional intensity, including unexpected memories or affect

Less common but serious considerations

  • Cardiovascular strain in people with underlying conditions
  • Urinary tract toxicity with frequent or high-dose use
  • Persistent perceptual changes in rare cases
  • Psychological dependence with unsupervised use
Less likely
More likely →
↑ More severe
Transient dissociation
Nausea / dizziness
Elevated BP / HR
Emotional intensity
Psychological dependence
Urinary toxicity (frequent use)
Persistent perceptual changes
Illustrative risk landscape — not a clinical scoring tool.

Contraindications and cautions

People with uncontrolled hypertension, certain cardiovascular disease, active psychotic disorders, certain substance use disorders, pregnancy, or specific other conditions may not be appropriate candidates. Some medications interact meaningfully with ketamine. A complete screening is essential.

  1. Phase 1
    Pre-dose
    Baseline vitals, consent, setting
  2. Phase 2
    Onset
    Dose administered, monitoring begins
  3. Phase 3
    Peak
    Dissociation, BP/HR closely tracked
  4. Phase 4
    Wind-down
    Effects subside, vitals re-checked
  5. Phase 5
    Discharge
    Aftercare plan, integration scheduled
A responsible supervised session has clearly defined phases and active monitoring throughout.

The role of supervision

Medical supervision is not a formality. It exists to monitor vital signs, manage adverse reactions, support psychological safety, and ensure dosing remains appropriate. Programs that minimize supervision or screening warrant skepticism.

Limits of current research

Long-term safety data, optimal dosing schedules, and use in adolescents, older adults, and pregnancy are areas where evidence remains limited. Responsible programs acknowledge these gaps rather than minimizing them.

Frequently asked questions

Who should not use ketamine therapy?+

People with uncontrolled hypertension or cardiovascular disease, active psychosis, certain substance use disorders, pregnancy, and specific other medical conditions may not be suitable candidates. A qualified clinician should perform a full medical and psychiatric screening.

Can ketamine be addictive?+

Ketamine has known abuse potential and can lead to psychological dependence, particularly with unsupervised, frequent, or high-dose use. Supervised medical protocols are designed to mitigate this risk, but it should not be ignored.

What are common side effects?+

Common transient effects include dissociation, dizziness, nausea, elevated blood pressure and heart rate, and emotional intensity. Most resolve within hours, but rare serious effects exist and warrant medical monitoring.

Educational use only. The content on this page is provided for general educational purposes and does not constitute medical advice, diagnosis, or treatment. Ketamine and related therapies carry risks and are appropriate only under qualified medical supervision. Always consult a licensed healthcare professional about your individual situation. Information may change as research evolves.